---
$id: https://graph.org.ai/products/commodity/51111772
$type: Product
source: UNSPSC
code: "51111772"
title: "Vinorelbine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vinorelbine

**UNSPSC Code**: 51111772
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C45H54N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q6C979R91Y, chemically known as c-norvincaleukoblastine, 3,4-didehydro-4-deoxy-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (salt) but generally known as vinorelbine, which bears US NIH Compound Identifier 60779. European Medicines Agency schedules Vinorelbine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00069MIG. The term VINORELBINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules vinorelbine in its Anatomical Therapeutic Chemical (ATC) Classification. VINORELBINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vinorelbine under HS 29399900 and SITC 54149. As of Q4 2014, VINORELBINE remains the US FDA Preferred Term for this commodity. Vinorelbine bears US NLM identifiers UMLS ID C0078257 and NCI Concept Code C1275. SMILES: O(C1C2(C3N(CCC43C(N(C3C4CC(C(OC)C3)C3(CC4CN(CC5C3[NH]C3C5CCCC3)CC(=C4)CC)C(=O)OC)C)C1(O)C(=O)OC)CC=C2)CC)C(=O)C.OC(C(O)C(=O)O)C(=O)O.OC(C(O)C(=O)O)C(=O)O.

